Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
R-GemOx as First-line Treatment in Elderly DLBCL
NCT01670370Phase 2Unknown
- Sponsor
- Jiangsu Provincial People's Hospital
- Start
- Aug 2012
- Primary completion
- Dec 2015
- Modality
- Monoclonal Antibodies, DNA Intercalators/Alkylators
01
Overview
A Phase 2 trial of rituximab, gemcitabine, oxaliplatin in diffuse large B-cell lymphoma (DLBCL), sponsored by Jiangsu Provincial People's Hospital. Status: unknown.
02
Drugs
rituximabgemcitabineoxaliplatin
03
Conditions
diffuse large B-cell lymphoma (DLBCL)
Beyond the preview
Go deeper on NCT01670370.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01670370.